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Abstract
Background: Ischemia within the optic nerve head (ONH) may contribute to retinal ganglion cell
(RGC) loss in primary open angle glaucoma (POAG). Ischemia has been reported to increase
neurotrophin and high affinity Trk receptor expression by CNS neurons and glial cells. We have
previously demonstrated neurotrophin and Trk expression within the lamina cribrosa (LC) region
of the ONH. To determine if ischemia alters neurotrophin and Trk protein expression in cells from
the human LC, cultured LC cells and ONH astrocytes were exposed to 48 hours of oxygen-glucose
deprivation (OGD). Also cells were exposed to 48 hours of OGD followed by 24 hours of
recovery in normal growth conditions. Cell number, neurotrophin and Trk receptor protein
expression, neurotrophin secretion, and Trk receptor activation were examined.
Results: Cell number was estimated using an assay for cell metabolism following 24, 48 and 72
hours of OGD. A statistically significant decrease in LC and ONH astrocyte cell number did not
occur until 72 hours of OGD, therefore cellular protein and conditioned media were collected at
48 hours OGD. Protein expression of NGF, BDNF and NT-3 by LC cells and ONH astrocytes
increased following OGD, as did NGF secretion. Recovery from OGD increased BDNF protein
expression in LC cells. In ONH astrocytes, recovery from OGD increased NGF protein
expression, and decreased BDNF secretion. Trk A expression and activation in LC cells was
increased following OGD while expression and activation of all other Trk receptors was decreased.
A similar increase in Trk A expression and activation was observed in ONH astrocytes following
recovery from OGD.
Conclusions: In vitro conditions that mimic ischemia increase the expression and secretion of
neurotrophins by cells from the ONH. Increased Trk A expression and activation in LC cells
following OGD and in ONH astrocytes following recovery from OGD suggest autocrine/paracrine
neurotrophin signaling could be a response to ONH ischemia in POAG. Also, the increase in NGF,
BDNF and NT-3 protein expression and NGF secretion following OGD also suggest LC cells and
ONH astrocytes may be a paracrine source of neurotrophins for RGCs.
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Background
Glaucoma is an optic neuropathy defined by characteristic
optic nerve head and associated visual field changes.
Nearly 67 million people worldwide are believed to have
glaucoma, including an estimated 2.2 million in the USA
[1,2]. Primary open-angle glaucoma (POAG) is the most
common form of glaucoma accounting for virtually half
of all cases [3]. The visual field changes associated with
POAG are due to the loss of retinal ganglion cells (RGCs),
which is proposed to occur via apoptosis [4,5]. There is
evidence that ischemia contributes to RGC loss in glau-
coma. Abnormal optic nerve head (ONH) and retinal
blood flow has been observed in glaucoma, and retinal
ischemia results in RGC loss [6-11]. In addition, excito-
toxicity due to elevated glutamate levels, which occurs fol-
lowing ischemia, can cause RGC death [12-16]. However,
not all cellular responses to ischemia are deleterious. The
expression of "protective factors", including neuro-
trophins (NTs), by neurons and glia within the CNS has
been shown to increase following ischemia [17-19].
Neurotrophins are polypeptide growth factors involved in
the development and maintenance of neurons, as well as
non-neuronal cells. Included in this family of trophic fac-
tors are nerve growth factor (NGF), brain-derived neuro-
trophic factor (BDNF), neurotrophin-3 (NT-3) and
neurotrophin 4 (NT-4). Neurotrophin signaling occurs
via two types of receptors including (a) tyrosine kinase
high affinity Trk receptors and (b) the low affinity p75
receptor [20]. The Trk receptors include Trk A, Trk B and
Trk C that bind NGF, BDNF and NT-4, and NT-3 respec-
tively [21]. Truncated isoforms of Trk B and Trk C that lack
the tyrosine kinase domain have been identified and their
function at this time is unknown, although there is evi-
dence that these receptors interfere with full-length trk sig-
naling through ligand sequestration [22-24].
In addition to their localization at axon terminals, Trk
receptors have been localized at neuronal cell bodies, at
dendritic projections, and along axons [25-27]. Discrete
signaling pathways can be activated and distinct biologi-
cal responses elicited in neurons depending on the loca-
tion of Trk receptor stimulation indicating neurons
respond not only to retrograde NT sources, but also to
paracrine and autocrine sources [28-31]. The lamina crib-
rosa (LC) region of the optic nerve head (ONH) is com-
posed of connective tissue plates that align to form a sieve-
like structure that guides and protects RGC axons as they
exit the eye to form the optic nerve. Two major cell types
have been isolated from the human LC and include ONH
astrocytes and LC cells [32-35]. We have previously dem-
onstrated the expression of NTs and their Trk receptors by
cells isolated from the human LC [36]. We also reported
that mRNA and protein for the low affinity p75 receptor
are not expressed by cells isolated from the human ONH.
In addition we have shown that LC cells and ONH astro-
cytes can respond to exogenous NTs via Trk phosphoryla-
tion resulting in cell proliferation and secretion of NTs
[37]. Due to the proximity of LC cells and ONH astrocytes
to RGC axons within the LC, these cells could serve as a
paracrine source of NTs for RGCs.
The administration of exogenous NTs has been shown to
protect neurons from ischemic damage [38,39] suggesting
endogenous NT sources could also be neuroprotective. A
recent report by Rudzinski et al. demonstrated that ocular
hypertension increased NGF and BDNF expression within
the retina [40]. Furthermore, Trk A expression in the retina
was increased following elevated intraocular pressure
(IOP), and this increase was observed in RGCs. Cui et al.
observed an increase in Trk A, Trk B and Trk C expression
in RGCs following optic nerve injury [41], again suggest-
ing a neuroprotective role for NTs in RGC injury.
In POAG, the laminar plates of the LC are compressed and
bow backward from the sclera producing an excavated
and exaggerated optic cup [42]. Because capillaries within
the LC are located in the connective tissue plates [43], ele-
vated IOP would likely compromise the blood flow to the
LC. Ischemic insults during the progression of POAG
could increase the expression and/or secretion of NTs
from LC cells and ONH astrocytes, thereby increasing
paracrine and/or autocrine NT signaling within the LC.
Given that ischemia can be a component of ocular hyper-
tension, we used oxygen-glucose deprivation (OGD) as an
acute model of in vitro ischemia and examined the expres-
sion of NTs and their receptors by cultured LC cells and
ONH astrocytes following OGD. We are aware that the
model used (oxygen and glucose deprivation) is not a per-
fect model for what occurs in the glaucomatous optic
nerve head. However, this acute model was an attempt to
mimic the end results of a chronic condition, and as a
"first step" we felt this model was adequate for examining
the response to injury in these cell types.
Results
Cell number following oxygen-glucose deprivation
The LC and ONH astrocyte cell lines used in this study
have been previously characterized and described [36].
Preliminary studies examining cell survival following
anoxia, hypoxia, hypoglycemia or serum withdrawl dem-
onstrated LC cells and ONH astrocytes were resistant to
hypoxia and serum withdrawl alone (data not shown). To
approach what is occurring in vivo, we used the more
acute oxygen-glucose deprivation (OGD) model to exam-
ine NT and trk expression, and NT signaling in cells from
the ONH.BMC Neuroscience 2004, 5:51 http://www.biomedcentral.com/1471-2202/5/51
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To determine an exposure of OGD that would result in
cellular changes while allowing a majority of cells to
remain viable, we examined cell number at various time
points of OGD using an assay that estimates cell number
based on cell metabolism. The oxygen level within the
anoxic incubator was determined to be below detectable
levels as measured using an Oxygen Test Kit (Bacharach
Inc., Pittsburgh, PA). Lamina cribrosa and ONH astrocyte
cell metabolism/cell number following OGD is shown in
Figure 1. Lamina cribrosa cell metabolism/cell number
did not decrease significantly until 72 hours OGD expo-
sure. At this time point a 40% decrease in LC cell metabo-
lism/cell number was observed. A 20% decrease in LC cell
metabolism/cell number was observed following 24 or 48
hours recovery when compared to the controls. ONH
astrocyte cell metabolism/cell number also decreased 20–
30% following 24–48 hours OGD. A statistically signifi-
cant 50% decrease in cell metabolism/cell number was
observed after 72 hours of OGD. Recovery increased ONH
astrocyte cell metabolism/cell number slightly when com-
pared to OGD. We chose to collect protein and condi-
tioned media following (a) 48 hours exposure to in vitro
Cell metabolism/cell number following exposure to and recovery from Oxygen-Glucose Deprivation Figure 1
Cell metabolism/cell number following exposure to and recovery from Oxygen-Glucose Deprivation. Lamina 
cribrosa cells and ONH astrocytes were exposed to oxygen-glucose deprivation (OGD), recovery following OGD or control 
conditions for the time points indicated. Three LC cell lines and three ONH astrocyte cell lines were assayed per experiment. 
A standard curve was generated for each cell line in order to calculate cell metabolism/cell number. Data shown as percent of 
the control and represents the mean ± SEM (n = 3). * indicates p < 0.008 (one way analysis of variance [ANOVA] followed by 
validation using Student-Newman-Keuls tests).BMC Neuroscience 2004, 5:51 http://www.biomedcentral.com/1471-2202/5/51
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NT protein expression in LC cells following exposure to and recovery from Oxygen-Glucose Deprivation Figure 2
NT protein expression in LC cells following exposure to and recovery from Oxygen-Glucose Deprivation. Lam-
ina cribrosa cells were exposed to OGD for 48 hours (OGD) or to 48 hours OGD followed by recovery for 24 hours 
(OGD+R). Cells exposed to growth media and 95% air/5% CO2 for 48 hours served as controls (C). Cell lysate was separated 
by SDS-PAGE and the density of unsaturated bands was measured for each blot. A representative blot for each NT is shown. 
Band density reported as mean percent of the control ± SEM (n = 3) is shown graphically beneath the blots. * indicates p < 
0.016 for OGD compared to C and OGD+R; † indicates p < 0.016 for OGD+R compared to C (one way analysis of variance 
[ANOVA] followed by validation using Student-Newman-Keuls tests).BMC Neuroscience 2004, 5:51 http://www.biomedcentral.com/1471-2202/5/51
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ischemia and (b) 48 hours in vitro ischemia plus 24 hours
recovery. We chose these time points since greater than
80% of LC cells and ONH astrocytes were present indicat-
ing that a majority of cells were viable.
Neurotrophin protein expression following oxygen-glucose 
deprivation
The expression of NT protein in LC cells and ONH astro-
cytes following OGD is shown in Figures 2 and 3. Multi-
ple isoforms for all four NTs were observed in LC cells and
ONH astrocytes. These isoforms most likely represent
proneurotrophins, premature forms of the NTs that have
recently been shown to possess biological activity [44]. A
representative blot for each NT is shown. Band density
reported as mean percent of the control ± SEM of three cell
lines is shown graphically beneath the blots. Western
blots for NTs and trks were stripped and re-probed for β-
actin to ensure equal loading. Expression of β-actin in LC
cells and ONH astrocytes was not significantly influenced
by OGD or recovery from OGD. The overall average β-
actin band density reported as a percent of the control ±
SEM for LC cells was 108% ± 7 following OGD exposure
and 96% ± 3 following recovery from OGD. Similar
changes were observed in ONH astrocytes (109% ± 8 fol-
lowing OGD and 107% ± 7 following recovery from
OGD).
As seen in Figure 2, the overall trend following 48 hours
of OGD was a decrease in NT protein expression by LC
cells. The exceptions to this trend were NGF (58 kDa),
BDNF (78 kDa), and NT-3 (57 kDa), of which only NT-3
(57 kDa) demonstrated a statistically significant increase
in protein expression following OGD. Of the remaining
NT isoforms, BDNF (67 kDa) and NT-4 (69 kDa) demon-
strated a statistically significant decrease in expression fol-
lowing OGD. A recovery period of 24 hours in growth
media and an aerobic environment following 48 hours
OGD resulted in elevated NT protein expression by LC
cells, however only BDNF (67 kDa) expression levels were
statistically significant.
Following 48 hours of OGD, ONH astrocytes (Figure 3)
demonstrated increased protein expression of NGF (58
kDa), NT-3 (57 kDa) and BDNF (78 kDa); only BDNF (78
kDa) was statistically significant. In addition, the expres-
sion of NGF (71 kDa) and BDNF (67 kDa) was decreased
to a statistically significant level following OGD.
Increased NT protein expression was the trend in ONH
astrocytes allowed to recover from OGD for 24 hours in
growth media and an aerobic environment. The excep-
tions were BDNF (78 kDa) and NT-4 (54 kDa), which
were slightly lower than control levels. Of the NT isoforms
where protein expression increased during recovery, only
NGF (71 kDa) demonstrated a statistically significant
increase. Western blot densitometry results for LC cells
and ONH astrocytes are summarized in Table 1.
Trk receptor protein expression following oxygen-glucose 
deprivation
Figure 4 represents the expression of Trk receptor protein
in LC cells following OGD or recovery from OGD. Data
are presented as described in the previous section. Protein
expression of Trk B and Trk C receptors decreased to a sta-
tistically significant level in LC cells following 48 hours of
OGD. In contrast, a statistically significant increase in the
expression of Trk A protein was observed following expo-
sure to OGD. Recovery from OGD resulted in a statisti-
cally significant decrease in Trk A and Trk C expression,
while Trk B and truncated Trk B protein expression was
elevated, but not to a statistically significant level.
The expression of Trk receptor protein by ONH astrocytes
following OGD and recovery from OGD is shown in Fig-
ure 5. A statistically significant decrease in the expression
of Trk A, Trk C and truncated Trk B protein by ONH astro-
cytes was observed following OGD. Trk B protein expres-
sion was also decreased, but not to a significant level.
Recovery from OGD increased Trk C and truncated Trk B
receptor protein expression in ONH astrocytes compared
to OGD alone. However, Trk C expression was still
decreased to a statistically significant level. Trk A and Trk
B protein expression was increased in ONH astrocytes
allowed to recover from OGD, although only Trk A
expression was statistically significant.
Phosphorylated Trk receptor protein expression following 
oxygen-glucose deprivation
The expression of phosphorylated Trk receptor protein
following OGD and recovery from OGD is shown in Fig-
ure 6. Data are presented as described above. Trk phos-
phorylation indicates the activation of Trk receptors
following NT binding. The antibody used was a phospho-
pan Trk antibody that recognizes phosphorylated forms of
Trk A, Trk B and Trk C receptors. Four phospho-Trk iso-
forms (148 kDa, 120 kDa, 80 kDa, and 72 kDa) were
detected in LC cell and ONH astrocyte controls. The 120
kDa and 72 kDa phospho-Trk isoforms most likely repre-
sent phosphorylated Trk A and Trk B respectively [37]. The
remaining phospho-Trk isoforms could represent phos-
phorylated forms of Trk A, B or C.
Overall, exposure to OGD resulted in decreased phospho-
Trk protein expression by LC cells and ONH astrocytes.
Expression of the 148 kDa phospho-trk isoform was
decreased to a statistically significant level in both LC cells
and ONH astrocytes, as was the 120 kDa and 80 kDa iso-
forms in ONH astrocytes. The only increase in phospho-
Trk receptor protein expression following OGD wasBMC Neuroscience 2004, 5:51 http://www.biomedcentral.com/1471-2202/5/51
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NT protein expression in ONH astrocytes following exposure to and recovery from Oxygen-Glucose Deprivation Figure 3
NT protein expression in ONH astrocytes following exposure to and recovery from Oxygen-Glucose Depriva-
tion. ONH astrocytes were exposed to OGD for 48 hours (OGD) or to 48 hours OGD followed by recovery for 24 hours 
(OGD+R). Cells exposed to growth media and 95% air/5% CO2 for 48 hours served as controls (C). Cell lysate was separated 
by SDS-PAGE and the density of unsaturated bands was measured for each blot. A representative blot for each NT is shown. 
Band density reported as mean percent of the control ± SEM (n = 3) is shown graphically beneath the blots. * indicates p < 
0.016 for OGD compared to C and OGD+R; † indicates p < 0.016 for OGD+R compared to C (one way analysis of variance 
[ANOVA] followed by validation using Student-Newman-Keuls tests).BMC Neuroscience 2004, 5:51 http://www.biomedcentral.com/1471-2202/5/51
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observed in LC cells. Protein expression of the 120 kDa
phospho-Trk receptor isoform was increased 60% over
the controls in LC cells, which was statistically significant.
Recovery from OGD resulted in increased protein expres-
sion of phospho-Trk receptor isoforms in LC cells and
ONH astrocytes when compared to OGD alone, with the
exception of the 120 kDa isoform in LC cells, which
decreased toward control levels. Although its expression
increased compared to OGD alone, expression of the 148
kDa isoform was still decreased to a significant level.
Interestingly, the 120 kDa phospho-trk isoform was again
the only isoform whose expression was increased above
control levels. This 100% increase was observed in ONH
astrocytes following recovery from OGD and was statisti-
cally significant.
Neurotrophin secretion following oxygen-glucose 
deprivation
The secretion of NGF and BDNF following OGD and
recovery from OGD is shown in Figure 7. Data are pre-
sented as mean percent of the control ± SEM of three LC
and three ONH astrocyte cell lines. The secretion of NGF
by LC cells and ONH astrocytes was increased over 200%
and 150% following OGD, respectively. This increase in
NGF secretion by cultured cells of the human LC was sta-
tistically significant. In contrast, BDNF secretion by both
cell types was decreased 60 to 90% following OGD, which
was statistically significant. Although recovery from OGD
returned NGF and BDNF secretion by LC cells toward con-
trols levels, a statistically significant decrease in BDNF
secretion by ONH astrocytes was observed. The secretion
of NT-3 or NT-4 was not detected by either cell type under
any condition.
Discussion
In this study we examined the protein expression of NTs
and Trk receptors by LC cells and ONH astrocytes follow-
ing OGD, an in vitro model of ischemia. Lamina cribrosa
cell and ONH astrocyte responses to OGD and recovery
from OGD are summarized in Tables 2 and 3. Lamina cri-
brosa cells and ONH astrocytes increased NGF, BDNF and
NT-3 protein expression following OGD. NGF secretion
by these cells was also increased by OGD at the time
points tested. Exposure to OGD decreased Trk protein
expression and activation in LC cells and ONH astrocytes,
with the exception of Trk A in LC cells. Recovery from
OGD resulted in most NT and Trk receptor protein expres-
sion returning toward control levels in LC cells and ONH
astrocytes. However, Trk A expression and activation in
ONH astrocytes remained significantly elevated over con-
trol levels. Overall, this study suggests that paracrine and/
or autocrine NT signaling is stimulated in cells from the
ONH following an ischemic insult. Alternatively, NT
release by ONH cells may act to protect RGCs from
ischemic injury.
Ischemia due to elevated IOP during POAG may cause
changes within the ONH and contribute to RGC loss [6-
11]. As a response to ischemia, neurons and glia have
been shown to increase the expression of NTs [17-19].
Local NT sources for RGCs within the retina and LC could
potentially protect these neurons during periods of ONH
ischemia in POAG. The recent report of Rudzinski et al.
Table 1: Summary of western blot densitometry data expressed in percent of the control ± SEM of three cell lines.
Lamina cribrosa cells ONH astrocytes
OGD OGD+R OGD OGD+R
NGF (71 kDa) 16 ± 7 162 ± 71 14 ± 4 118 ± 7
NGF (58 kDa) 264 ± 67 106 ± 3 157 ± 18 122 ± 39
BDNF (78 kDa) 1244 ± 414 265 ± 152 288 ± 75 78 ± 20
BDNF (67 kDa) 22 ± 6 151 ± 22 22 ± 9 121 ± 13
NT-3 (78 kDa) 57 ± 12 120 ± 52 145 ± 13 129 ± 32
NT-3 (57 kDa) 213 ± 37 77 ± 20 188 ± 22 126 ± 32
NT-4 (69 kDa) 8 ± 7 119 ± 30 4 ± 3 117 ± 30
NT-4 (54 kDa) 32 ± 13 98 ± 35 44 ± 12 85 ± 13
Trk A 175 ± 15 54 ± 12 53 ± 7 178 ± 21
Trk B 25 ± 9 150 ± 24 57 ± 38 157 ± 33
Trk C 46 ± 9 63 ± 7 25 ± 7 73 ± 3
Trk B.T 65 ± 16 132 ± 26 40 ± 8 99 ± 7
pTrk (148 kDa) 23 ± 9 37 ± 10 12 ± 10 59 ± 16
pTrk (120 kDa) 162 ± 16 93 ± 8 19 ± 14 204 ± 19
pTrk (80 kDa) 80 ± 14 92 ± 12 6 ± 4 104 ± 18
pTrk (72 kDa) 13 ± 7 70 ± 18 4 ± 3 77 ± 13BMC Neuroscience 2004, 5:51 http://www.biomedcentral.com/1471-2202/5/51
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[40] is of interest as they demonstrated an up-regulation
of both NGF and Trk A after 7 days of ocular hypertension,
and a sustained up-regulation of BDNF after 28 days ele-
vated IOP. We have previously demonstrated NT expres-
sion and secretion by LC cells and ONH astrocytes [36].
The LC region of the ONH and the cells that reside there
may be subject to ischemic injury during the progression
of POAG. Therefore, we examined cell number as
determined by cell metabolism following OGD to deter-
mine if LC cells and ONH astrocytes could survive
ischemic insult. Lamina cribrosa cell metabolism/cell
number remained within 15% of the controls until 72
hours of OGD, whereas ONH astrocyte cell metabolism/
cell number decreased 20–30% over the same exposure
time. Lamina cribrosa and ONH astrocyte cell metabo-
lism/cell number returned to within 20% of the controls
following recovery from OGD. These results suggest LC
cells and ONH astrocytes can survive ischemic injury and
therefore could be a potential source of neuroprotective
factors.
Neurons, including RGCs, express Trk receptors not only
at the axon terminal and cell body, but also along their
axons [25-27] suggesting RGCs could bind NTs provided
by cells of the ONH. We examined the expression and
secretion of NTs by LC cells and ONH astrocytes following
OGD to determine if these cells could potentially protect
RGCs from ischemic injury. The expression of NGF, BDNF
and NT-3 by LC cells and ONH astrocytes increased after
exposure to OGD. Examination of NT mRNA levels in LC
cells and ONH astrocytes following OGD would deter-
mine whether this is due to an up-regulation in expression
or to increased processing of proNTs. Interestingly, only
NGF secretion by LC cells and ONH astrocytes was
increased by OGD. It is possible that BDNF and NT-3 are
secreted by LC cells and ONH astrocytes following OGD,
but at time points other than those examined or at lower
Trk receptor protein expression in LC cells following exposure to and recovery from Oxygen-Glucose Deprivation Figure 4
Trk receptor protein expression in LC cells following exposure to and recovery from Oxygen-Glucose Depri-
vation. Lamina cribrosa cells were exposed to OGD for 48 hours (OGD) or to 48 hours OGD followed by recovery for 24 
hours (OGD+R). Cells exposed to growth media and 95% air/5% CO2 for 48 hours served as controls (C). Cell lysate was sep-
arated by SDS-PAGE and the density of unsaturated bands was measured for each blot. A representative blot for each Trk 
receptor is shown. Band density reported as mean percent of the control ± SEM (n = 3) is shown graphically beneath the blots. 
* indicates p < 0.016 for OGD compared to C and OGD+R; † indicates p < 0.016 for OGD+R compared to C (one way anal-
ysis of variance [ANOVA] followed by validation using Student-Newman-Keuls tests). Trk B.T; truncated Trk B.BMC Neuroscience 2004, 5:51 http://www.biomedcentral.com/1471-2202/5/51
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detection levels. Overall, the responses to OGD by LC
cells and ONH astrocytes with respect to the expression of
NTs appeared favorable to RGCs. Neurotrophin expres-
sion was increased in both cell types, as was NGF secre-
tion. Thus it appears LC cells and ONH astrocytes could
provide RGCs with neuroprotective factors following
ischemic injury.
The expression of Trk receptors (both full length and trun-
cated) by LC cells, ONH astrocytes or other cells within
the LC could limit NT availability to RGCs [22-24].
Therefore, we examined Trk protein expression and activa-
tion in LC cells and ONH astrocytes following OGD. Trk
receptor expression was decreased in LC cells and ONH
astrocytes following OGD, with the significant exception
of Trk A in LC cells. As an indication of NT signaling, we
examined the expression of phosphorylated Trk receptors
in LC cells and ONH astrocytes following OGD. Phospho-
Trk A expression in LC cells was increased after OGD,
while all other phospho-Trk expression was decreased.
The up-regulation of autocrine NGF signaling in LC cells
(e.g. NGF secretion and Trk A expression) could explain
the differences observed between LC and ONH astrocyte
cell number in following OGD. In a previous report we
demonstrated that exogenous NGF increased LC cell
number [37]. As LC cells do not express p75, this response
is most likely due to Trk A activation. Together these data
suggest Trk expression by ONH astrocytes would not
interfere with NT availability to RGCs during ischemia. In
contrast, increased expression of Trk A in LC cells resulted
in increased Trk A activation, implying NGF expression in
these cells during ischemia may be self protective rather
than protective toward RGCs.
There is evidence that reperfusion following ischemia is
actually more detrimental to cells than ischemia itself
[45,46]. To determine if cells from the LC could provide
RGCs with NT support during reperfusion of the ONH in
Trk receptor protein expression in ONH astrocytes following exposure to and recovery from Oxygen-Glucose Deprivation Figure 5
Trk receptor protein expression in ONH astrocytes following exposure to and recovery from Oxygen-Glucose 
Deprivation. ONH astrocytes were exposed to OGD for 48 hours (OGD) or to 48 hours OGD followed by recovery for 24 
hours (OGD+R). Cells exposed to growth media and 95% air/5% CO2 for 48 hours served as controls (C). Cell lysate was sep-
arated by SDS-PAGE and the density of unsaturated bands was measured for each blot. A representative blot for each Trk 
receptor is shown. Band density reported as mean percent of the control ± SEM (n = 3) is shown graphically beneath the blots. 
* indicates p < 0.016 for OGD compared to C and OGD+R; † indicates p < 0.016 for OGD+R compared to C (one way anal-
ysis of variance [ANOVA] followed by validation using Student-Newman-Keuls tests). Trk B.T; truncated Trk B.BMC Neuroscience 2004, 5:51 http://www.biomedcentral.com/1471-2202/5/51
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Phosphorylated Trk protein expression following exposure to and recovery from Oxygen-Glucose Deprivation Figure 6
Phosphorylated Trk protein expression following exposure to and recovery from Oxygen-Glucose Depriva-
tion. Lamina cribrosa cells and ONH astrocytes were exposed to OGD for 48 hours (OGD) or to 48 hours OGD followed by 
recovery for 24 hours (OGD+R). Cells exposed to growth media and 95% air/5% CO2 for 48 hours served as controls (C). 
Cell lysate was separated by SDS-PAGE and the density of unsaturated bands was measured for each blot. A representative 
blot for each phospho-Trk receptor isoform is shown. Band density reported as mean percent of the control ± SEM (n = 3) is 
shown graphically beneath the blots. * indicates p < 0.016 for OGD compared to C and OGD+R; † indicates p < 0.016 for 
OGD+R compared to C (one way analysis of variance [ANOVA] followed by validation using Student-Newman-Keuls tests).BMC Neuroscience 2004, 5:51 http://www.biomedcentral.com/1471-2202/5/51
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POAG, we examined NT and Trk receptor expression fol-
lowing recovery from OGD. ONH astrocytes could be a
source of NTs for RGCs during reperfusion of the ONH as
an increase in NGF protein expression was observed in
these cells after recovery from OGD. However, recovery
from OGD also increased Trk A expression and activation
in ONH astrocytes, implying these cells up-regulate auto-
crine/paracrine NGF signaling during recovery from an
ischemic event. In addition, Trk B receptor expression by
LC cells and ONH astrocytes increased after recovery from
OGD suggesting NT availability to RGC axons within the
LC may be compromised during ONH reperfusion. Based
on these results, LC cells and ONH astrocytes would be
unable to provide RGCs with NTs during reperfusion of
the ONH. Increased NT expression by LC cells and ONH
astrocytes during ONH ischemia could protect RGCs from
injury; however, as blood flow was restored NT expression
by LC cells and ONH astrocytes would decrease to normal
levels, leaving RGCs vulnerable to injury. Neurotrophin
expression by LC cells and ONH astrocytes may be bene-
ficial to RGCs during ischemia, but may be unable to pro-
mote the survival of these neurons during reperfusion.
In conclusion, we have demonstrated that LC cells and
ONH astrocytes increase the expression of NGF, BDNF
and NT-3 protein following OGD, which may be
neuroprotective for RGCs. Neurotrophins expressed by LC
cells and ONH astrocytes following OGD or recovery
from OGD bind and activate Trk receptors expressed by
these cells. Increased NT signaling within LC cells and
ONH astrocytes could increase cell survival following
ischemic injury, but may compromise RGC survival dur-
ing reperfusion. Further studies examining the expression
of NTs and Trk receptors following hypoxia or transient
ischemic insults would provide a better model for
ischemic injury in POAG. Using this model, RGCs could
be co-cultured with LC cells or ONH astrocytes to deter-
mine the neuroprotective effects of NTs during ischemic
injury. By better understanding NT signaling within the
LC under normal and injurious conditions, new strategies
involving these factors could be developed to better treat
patients with POAG.
NT secretion following exposure to and recovery from Oxy- gen-Glucose Deprivation Figure 7
NT secretion following exposure to and recovery 
from Oxygen-Glucose Deprivation. Lamina cribrosa 
cells and ONH astrocytes were exposed to OGD for 48 
hours (OGD) or to 48 hours OGD followed by recovery for 
24 hours (OGD+R). NGF and BDNF secretion was deter-
mined by immunoassay of concentrated conditioned media 
from three LC cell lines and three ONH astrocyte cell lines. 
A NT standard was included in each assay and was used to 
generate a standard curve. Data are reported as percent of 
the control ± SEM (n = 3). * indicates p < 0.016 for OGD 
compared to C and OGD+R; † indicates p < 0.016 for 
OGD+R compared to C (one way analysis of variance 
[ANOVA] followed by validation using Student-Newman-
Keuls tests).
Table 2: Lamina cribrosa cell and ONH astrocyte responses to oxygen-glucose deprivation.
Lamina cribrosa cells ONH astrocytes
Cell Number 95 % survival at 24 hrs, 85% at 48 hrs 70 % survival at 24 hrs, 80% at 48 hrs
NT Expression ↑ NGF, ↑ BDNF, ↑ NT-3; ↓ NT-4 ↑ BDNF, ↑ NT-3; ↓ NGF, ↓ NT-4
Trk Expression ↑ Trk A; ↓ Trk C, ↓ Trk B ↓ Trk A, ↓ Trk C, ↓ Trk B.T
Phospho-Trk Expression ↑ 120 kDa isoform (Trk A); ↓ 148 kDa isoform ↓ all phospho-trk receptors
isoform
Secretion of NTs ↑ NGF; ↓ BDNF ↑ NGF; ↓ BDNFBMC Neuroscience 2004, 5:51 http://www.biomedcentral.com/1471-2202/5/51
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Conclusions
Lamina cribrosa cells and ONH astrocytes respond to con-
ditions that mimic ONH ischemia by increasing NGF,
BDNF and NT-3 protein expression and NGF secretion.
Increased protein expression of Trk receptors and phos-
phorylated Trk receptors by LC cells and ONH astrocytes
following OGD and recovery from OGD respectively sug-
gest paracrine and/or autocrine NT signaling occurs
within the ONH following ischemic injury.
Lamina cribrosa cells and ONH astrocytes may be a para-
crine source of NGF, BDNF and/or NT-3 for RGCs, espe-




DMEM and fetal bovine serum (FBS) were purchased
from HyClone Labs, Logan, UT. The following materials
were purchased from Gibco BRL Life Technologies, Grand
Island, NY; glucose free DMEM, L-glutamine, penicillin/
streptomycin and fungizone (amphotericin B). Costar 96-
well plates and Nunc ELISA/EIA 96 well Maxisorp plates
were purchased from Fisher Scientific, Pittsburgh, PA. Pol-
yclonal antibodies to Trk A, Trk B, Trk C, truncated Trk B
(Trk B.T) and phosphorylated Trk were purchased from
Santa Cruz Biotechnology Inc, Santa Cruz, CA. CellTiter
96® Aqueous Non-Radioactive Cell Proliferation Assays
and Emax™ ImmunoAssay Systems specific for NGF,
BDNF, NT-3 and NT-4 were purchased from Promega
Corporation, Madison, WI.
Lamina cribrosa and ONH astrocyte cell culture
Lamina cribrosa and ONH astrocyte cell lines were
obtained from human LC explants from separate donors
as described previously [36]. Cells were cultured in Ham's
F-10 Media (LC cells, JRH Biosciences, Lenexa, KS) or
DMEM (ONH astrocytes) supplemented with 10% FBS, L-
glutamine (0.292 mg/ml), penicillin (100 units/ml)/
streptomycin (0.1 mg/ml), and amphotericin B (4 µg/ml)
as previously described. Cells were passaged using a
0.25% trypsin solution (Sigma-Aldrich, St. Louis, MO).
All cultures were maintained in 5% CO2/95% air at 37°C
and media was changed every 2 to 3 days. Characteriza-
tion of these cells was performed as described previously
[36]. Cells expressing α-smooth muscle actin that did not
express glial fibrillary acidic protein (GFAP) were charac-
terized as LC cells [32,33,36]. Cells expressing GFAP and
neural cell adhesion molecule (N-CAM) were character-
ized as ONH astrocytes [34-36]. Both cell types expressed
extracellular matrix proteins, such as collagen I, collagen
III, collagen IV and elastin [32,33,36]. Adult cell lines
from donors whose ages ranged from 39 years to 90 years
were used in the following experiments.
Oxygen-glucose deprivation
Preliminary studies examining cell survival following
anoxia, hypoxia, hypoglycemia or serum withdrawl dem-
onstrated LC cells and ONH astrocytes were resistant to
hypoxia and serum withdrawl alone (data not shown). To
approach what is occurring in vivo, we used the more
acute oxygen-glucose deprivation (OGD) model to exam-
ine NT and trk expression and NT signaling in cells from
the ONH. Preconfluent, age-matched adult LC cells and
ONH astrocytes were treated with serum free media for 24
hours. Oxygen-glucose deprivation (OGD) was achieved
by culturing LC cells and ONH astrocytes in glucose free
serum free DMEM in an anoxic incubator (95% N2/5%
CO2) for 48 hours. The oxygen level within the anoxic
incubator was measured using a Oxygen Test Kit (Bachar-
ach Inc., Pittsburgh, PA) and was determined to be below
detectable levels. Recovery following OGD was achieved
by placing cells in OGD conditions for 48 hours and then
allowing them to recover in growth media (Ham's F-10
Media or DMEM plus 10% FBS) and an aerobic environ-
ment (95% air/5% CO2) for 24 hours. Cells cultured in
growth media and an aerobic environment for served as
controls.
Determination of cell number based upon cell metabolism 
following oxygen-glucose deprivation
Adult LC cells and ONH astrocytes were trypsinized,
counted using a hemacytometer and plated into Costar
96-well plates at a density of 1,000 cells/well. Cells were
allowed to attach overnight and were then placed in
Table 3: Lamina cribrosa cell and ONH astrocyte responses to recovery following oxygen-glucose deprivation.
Lamina cribrosa cells ONH astrocytes
Cell Number 80 % survival 80 % survival
NT Expression ↑ BDNF; others near control levels ↑ NGF
Trk Expression ↓ Trk A, ↓ Trk C ↑ Trk A
Phospho-Trk Expression ↓ 148 kDa isoform; others near control levels ↑ 120 kDa isoform (Trk A); ↓ 148 kDa isoform
Secretion of NTs near control levels ↓ BDNFBMC Neuroscience 2004, 5:51 http://www.biomedcentral.com/1471-2202/5/51
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serum free media for 24 hours. Lamina cribrosa cells and
ONH astrocyte were exposed to OGD as described above
for 24, 48 or 72 hours. Recovery following OGD was
achieved by placing cells in OGD conditions for 24 or 48
hours and then allowing them to recover in growth media
and an aerobic environment (95% air/5% CO2) for 24
hours. Cells cultured in growth media and an aerobic
environment for served as controls.
Cell number was estimated using the CellTiter 96® Aqueous
Non-Radioactive Cell Proliferation Assay which measures
product from a metabolic process to estimate cell number.
Following exposure to OGD or recovery from OGD,
media was removed and replaced with 100 µl of serum
free media. Twenty microliters of MTS/PMS solution was
added to each well. Plates were incubated at 95% air/5%
CO2 at 37°C for 1 hour, at which time the absorbance at
490 nm was read using a SpectraMax® 190 microplate
reader and Softmax® Pro (Molecular Devices Corporation,
Sunnyvale, CA). Metabolically active cells convert MTS
into formazan, which is soluble in aqueous solutions. The
quantity of the formazan product measured by the
amount of absorbance at 490 nm is therefore directly pro-
portional to the number of living cells. Cell metabolism/
cell number per well was calculated from a standard curve
generated using known amounts of cells per well. A stand-
ard curve was generated for each cell line assayed. Three
LC cell lines and three ONH astrocyte cell lines were
assayed. The entire experiment, including standard curves,
was repeated twice. Changes in cell metabolism/cell
number following OGD and recovery from OGD were
reported as a percent of the control ± SEM.
Protein extraction and western blot analysis
Cellular protein was collected in lysis buffer modified
from Watson et al. [47] [20 mM Tris (pH 7.4), 137 mM
NaCl, 1% NP40, 10% glycerol, 48 mM sodium fluoride,
16 mM sodium pyrophosphate, 1 mM PMSF, 20 µM leu-
peptin, 10 µg/ml aprotinin, and 1 mM sodium orthovana-
date (10 µl/ml)]. Protein concentration was measured
using the Bio-Rad Dc Protein Assay System (Bio-Rad Lab-
oratories, Richmond, CA). Cellular lysate (50 µg) was sep-
arated on denaturing polyacrylamide gels and then
transferred by electrophoresis to nitrocellulose mem-
branes. Blots were processed using primary antibodies
and the Western Breeze Chemiluminescent Immunode-
tection System (Invitrogen, Carlsbad, CA). Blots were then
exposed to Hyperfilm-ECL (Amersham, Arlington
Heights, IL) for various times depending on the amount
of target protein present. The density (O.D. × mm2) of
unsaturated bands was measured using the Discovery
Series scanner and the Diversity One program from pdi
(Huntington, NY) and a digital Venturis FP466 computer
(Compaq, Houston, TX). Western blots for NTs and trks
were stripped and re-probed for β-actin to ensure equal
loading.
Conditioned media and immunoassays
Conditioned media was collected and concentrated using
Millipore Centriplus YM-3 Centrifugal Filter Devices (Mil-
lipore Corporation, Bedford, MA). Emax™ ImmunoAssay
Systems specific for NGF, BDNF, NT-3 and NT-4
(Promega) were performed according to manufacturer's
instructions. Conditioned media was added to Nunc
ELISA/EIA 96 well Maxisorp plates coated with anti-NT
polyclonal antibodies. Secreted NT was detected by treat-
ing the plates with the respective NT monoclonal
antibody followed by a horseradish peroxidase conju-
gated secondary antibody. Enzyme substrate was added to
generate a color product whose absorbance was read at
450 nm. A NT standard included in each assay was used
to generate a standard curve that was used to calculate the
amount of secreted NT per well. The amount of secreted
NT per sample was normalized to total protein per sam-
ple. Samples were assayed in triplicate. Conditioned
media from three LC cell lines and three ONH astrocyte
cell lines were assayed. Each immunoassay was repeated
twice. Changes in NT secretion following OGD and recov-
ery from OGD were reported as a percent of the control ±
SEM.
Statistical analysis
Cell metabolism/cell number, western blot densitometry
and immunoassay data were analyzed using one way
analysis of variance (ANOVA) followed by validation
using Student-Newman-Keuls tests. The MedCalc® statisti-
cal package, version 7.4.41 [48] was used for statistical
analysis. Significance values were adjusted in accordance
with Bonferroni's correction for multiple tests [49].
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